Suchergebnisse - "Fintelman-Rodrigues, Natalia"

PubPharm (5)

1

VIP plasma levels associate with survival in severe COVID-19 patients, correlating with protective effects in SARS-CoV-2-infected cells

enthalten in: Journal of leukocyte biology | 2022

von Temerozo, J. | Sacramento, C. | Fintelman-Rodrigues, N. | +14

2

Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture

enthalten in: Communications biology | 2022

von Wang, X. | Sacramento, C. | Jockusch, S. | +16

UpdateOf: bioRxiv. 2021 Jul 21;:. - PMID 34312622

3

In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19

enthalten in: The Journal of antimicrobial chemotherapy | 2021

von Sacramento, C. | Fintelman-Rodrigues, N. | Temerozo, J. | +37

4

Influenza virus RNA polymerase may be activated inside the virion

enthalten in: The Journal of general virology | 2018

von Sacramento, C. | Fintelman-Rodrigues, N. | Miranda, M. | +2

5

Oseltamivir-resistant influenza A(H1N1)pdm2009 strains found in Brazil are endowed with permissive mutations, which compensate the loss of fitness imposed by antiviral resistance

enthalten in: Memorias do Instituto Oswaldo Cruz | 2015

von Lopes e Souza, T. | Fintelman-Rodrigues, N. | Resende, P. | +8

1
[1]